Bloomberg
By Greg Stohr and Jef Feeley -
Jun 20, 2011 10:01 AM MT
The U.S. Supreme Court refused to hear a Pfizer Inc. (PFE) unit’s appeal of a $58 million award to three Nevada women who contracted breast cancer after taking the company’s Premarin and Prempro menopause drugs.

Follow Us!